These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24699418)

  • 1. Studies on biological macromolecules lipid-Gelucire based gastroretentive multiparticulate.
    Upadhyay P; Pandit JK; Wahi AK
    Int J Biol Macromol; 2014 Jun; 67():463-77. PubMed ID: 24699418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B; Tadikonda RR; Vemula SK
    Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery.
    Date AA; Vador N; Jagtap A; Nagarsenker MS
    Nanotechnology; 2011 Jul; 22(27):275102. PubMed ID: 21606564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design.
    Patel DM; Patel NM; Patel VF; Bhatt DA
    AAPS PharmSciTech; 2007 Apr; 8(2):Article 30. PubMed ID: 17622108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of semicrystalline copolymers in solid dispersions of pioglitazone hydrochloride: in vitro-in vivo correlation.
    Swain RP; Subudhi BB
    Drug Dev Ind Pharm; 2019 May; 45(5):775-786. PubMed ID: 30675819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrusion-spheronization manufacture of Gelucire matrix beads.
    Montoussé C; Pruvost M; Rodriguez F; Brossard C
    Drug Dev Ind Pharm; 1999 Jan; 25(1):75-80. PubMed ID: 10028421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of a gastroretentive drug delivery system for metformin HCl using synthetic and semi-synthetic polymers.
    Meka VS; Gorajana A; Dharmanlingam SR; Kolapalli VR
    Invest Clin; 2013 Dec; 54(4):347-59. PubMed ID: 24502177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suitability of Gelucire 50/13 for controlled release formulation of salbutamol sulphate.
    Mohsin S; Rahman NU; Idrees MA; Sarfraz MK; Khan MK; Mustafa G
    Pak J Pharm Sci; 2012 Jan; 25(1):35-41. PubMed ID: 22186307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH; Bandari S; Jukanti R; Veerareddy PR
    Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Gelucire 43/01 beads of metformin hydrochloride for floating delivery.
    Jain SK; Gupta A
    AAPS PharmSciTech; 2009; 10(4):1128-36. PubMed ID: 19830579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: in-vitro optimization and in-vivo performance in humans.
    Abouelatta SM; Aboelwafa AA; Khalil RM; ElGazayerly ON
    Eur J Pharm Biopharm; 2015 Jan; 89():82-92. PubMed ID: 25448073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: preparation and in vitro/in vivo evaluation.
    He W; Li Y; Zhang R; Wu Z; Yin L
    Int J Pharm; 2014 Dec; 476(1-2):223-31. PubMed ID: 25283698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.
    Basak SC; Rahman J; Ramalingam M
    Pharmazie; 2007 Feb; 62(2):145-8. PubMed ID: 17341036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A; El-Menshawe S; Afouna M
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of novel lipid based gastroretentive delivery system: response surface analysis, in-vivo imaging and pharmacokinetic study.
    Ahmed Abdelbary A; Elsayed I; Hassen Elshafeey A
    Drug Deliv; 2015 Jan; 22(1):37-49. PubMed ID: 24350634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of cefuroxime axetil biphasic floating minitablets.
    Jammula S; Patra ChN; Swain S; Panigrahi KC; Nayak S; Dinda SC; Rao ME
    Drug Deliv; 2015 Jan; 22(1):125-35. PubMed ID: 24417642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma scintigraphic evaluation of floating gastroretentive tablets of metformin HCl using a combination of three natural polymers in rabbits.
    Razavi M; Karimian H; Yeong CH; Chung LY; Nyamathulla S; Noordin MI
    Drug Des Devel Ther; 2015; 9():4373-86. PubMed ID: 26273196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the mechanisms of drug release from glyceride bases.
    Sutananta W; Craig DQ; Newton JM
    J Pharm Pharmacol; 1995 Mar; 47(3):182-7. PubMed ID: 7602477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance.
    Schamp K; Schreder SA; Dressman J
    Eur J Pharm Biopharm; 2006 Apr; 62(3):227-34. PubMed ID: 16246538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.